AI English summary of an SEC filing — figures as filed
The company said revenue for Q2 2024 rose to $17.492 billion from $15.861 billion a year earlier, and net income attributable to HCA Healthcare was $1.461 billion, or $5.53 per diluted share. Net income for the prior-year quarter was $1.193 billion, or $4.29 per diluted share.
Key points
AI summaryThe company said revenue for Q2 2024 rose to $17.492 billion from $15.861 billion a year earlier, and net income attributable to HCA Healthcare was $1.461 billion, or $5.53 per diluted share. Net income for the prior-year quarter was $1.193 billion, or $4.29 per diluted share.
HCA Healthcare said consolidated revenues rose 10.3% in Q2, citing a 6.0% increase in equivalent admissions and a 4.1% increase in revenue per equivalent admission as the main drivers. Surgeries fell 0.3% on a consolidated basis over the same period.
The company said salaries and benefits were 43.9% of revenue in Q2, compared with 45.9% a year earlier, and that contract labor declined 25.7%. By contrast, other operating expenses were 20.7% of revenue, higher than 19.2% a year earlier.
HCA Healthcare said cash provided by operating activities was $4.440 billion for the first six months of 2024. It repurchased shares for $2.547 billion and paid dividends of $356 million. Working capital as of June 30, 2024 was $40.880 billion.
Key figures
Quarter ended June 30, 2024
- Revenue
- $17.5B
- Net income
- $1.5B
- EPS
- $5.53
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Q2 2024 Revenue and Net Income
The company said revenue for Q2 2024 rose to $17.492 billion from $15.861 billion a year earlier, and net income attributable to HCA Healthcare was $1.461 billion, or $5.53 per diluted share. Net income for the prior-year quarter was $1.193 billion, or $4.29 per diluted share.
Source · Based on the MD&A text of the filing
Revenue Growth and Volume Trends
HCA Healthcare said consolidated revenues rose 10.3% in Q2, citing a 6.0% increase in equivalent admissions and a 4.1% increase in revenue per equivalent admission as the main drivers. Surgeries fell 0.3% on a consolidated basis over the same period.
Source · Based on the MD&A text of the filing
Q2 Cost Structure
The company said salaries and benefits were 43.9% of revenue in Q2, compared with 45.9% a year earlier, and that contract labor declined 25.7%. By contrast, other operating expenses were 20.7% of revenue, higher than 19.2% a year earlier.
Source · Based on the MD&A text of the filing
6-Month Cash Flow and Debt
HCA Healthcare said cash provided by operating activities was $4.440 billion for the first six months of 2024. It repurchased shares for $2.547 billion and paid dividends of $356 million. Working capital as of June 30, 2024 was $40.880 billion.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…